Our team is composed of experienced leaders and multidisciplinary scientists.
Driving complex scientific programs, we work in a flat organizational structure relying strongly on the expertise contributed by each of us.
24 employees
50% PhD
46% women
Keyhan Alvandipour
Data scientist
Jennifer Arthur Ataam, PhD
Senior scientist
Mona Boyé, PhD
Head of business development
Léa Chemardin-Liss
Office manager
Thomas Chrétien
Finance controller
Konstantinos Gkatzis, PhD
Head of cardiovascular projects
Bénédicte Gobert
Scientist
Zahra Hanifehlou, PhD
Data scientist
Helmut Haning, PhD
Chief Operations Officer
David Hoffmann
Research technician
François Kien, PhD
Operations manager
Ombline Conrad, PhD
Senior Scientist
Antoine de Lacombe
Chief Executive Officer
Arnaud Ogier, PhD
Head of Data & image analysis
Myrto Patraskaki, PhD
Senior scientist
Arnaud Poret, PhD
Head of bio-informatics
Karen Schmitt, PhD
Head of neuro-developmental projects
Peter Sommer, PhD
Head of science
Amélie Weiss
Head of HTS/HCS screening
Marion Wendenbaum
Research technician
Nicolas Wiest-Daesslé, PhD
Senior data scientist
Johannes Wilbertz, PhD
Head of neuro-degenerative projects
Antoine de Lacombe
Managing director
Graduated from Université Paris-Dauphine in management and Institut d’Etudes Politiques de Paris in corporate finance, Antoine started with Ernst & Young. He then joined a privately-owned group where he gained experience in corporate finance and restructuring. Antoine is the managing director of Ksilink.
Mona Boyé, pHD
Head of Business development and partnerships
With a PhD in molecular Biology from Cardiff University, UK, Mona worked several years as a Technology Transfer Officer at the CNRS and was heading a team of Innovation and Matchmaking Officers at the trinational, industrial cluster BioValley. She accumulated over 15 years of experience in technology transfer and open innovation before joining the Ksilink team in 2016.
Peter Sommer, pHD
Scientific director
Graduated in Virology from the University of the Saarland, Peter worked on retroviruses at the Institut Pasteur in Paris and headed a translational research team at the Institut Pasteur Korea in Seoul. Peter has gathered 15 years of experience in translational research and drug discovery in Europe and Asia before joining Ksilink in 2014.